Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Changes in Gene Expression during G-CSF-Induced Emergency Granulopoiesis in Humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. PPARs and the development of Type 1 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  3. Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. L-serine: a neglected amino acid with a potential therapeutic role in diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  5. Oral LPS Dosing Induces Local Immunological Changes in the Pancreatic Lymph Nodes in Mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Klára Dáňová
  • Anna Grohová
  • Pavla Strnadová
  • David P Funda
  • Zdeněk Šumník
  • Jan Lebl
  • Ondřej Cinek
  • Štěpánka Průhová
  • Stanislava Koloušková
  • Barbora Obermannová
  • Lenka Petruželková
  • Anna Šedivá
  • Petra Fundová
  • Karsten Buschard
  • Radek Špíšek
  • Lenka Palová-Jelínková
View graph of relations

Tolerogenic dendritic cells (tolDCs) may offer an interesting intervention strategy to re-establish Ag-specific tolerance in autoimmune diseases, including type 1 diabetes (T1D). T1D results from selective destruction of insulin-producing β cells leading to hyperglycemia that, in turn, specifically affects a patient's immune system. In this study, we prepared monocyte-derived tolDCs modulated by dexamethasone and vitamin D2 from 31 T1D patients with optimal glycemic control and 60 T1D patients with suboptimal glycemic control and assessed their tolerogenic properties in correlation with metabolic state of patients. tolDCs differentiated from both groups of patients acquired a regulatory phenotype and an anti-inflammatory profile. Interestingly, tolDCs from well-controlled patients expressed higher levels of inhibitory molecules IL-T3 and PD-L1. Additionally, glutamic acid decarboxylase (GAD)65-loaded tolDCs from well-controlled patients decreased significantly primary Th1/Th17 responses, induced stable GAD65-specific T cell hyporesponsiveness, and suppressed markedly control DC-induced GAD65-specific T cell activation compared with poorly controlled patients. The ability of tolDCs from poorly controlled patients to induce durable GAD65-specific T cell hyporesponsiveness was reversed once the control of glycemia improved. In both groups of patients, tolDCs were able to induce regulatory T cells from autologous naive CD4(+) T cells. However, regulatory T cells from well-controlled patients had better suppressive abilities. The functionality of tolDCs was confirmed in the adoptive transfer model of NOD-SCID mice where tolDCs delayed diabetes onset. These results suggest that metabolic control of T1D affects the functional characteristics of tolDCs and subsequent effector T cell responses. Metabolic control may be relevant for refining inclusion criteria of clinical trials in the settings of T1D.

Original languageEnglish
JournalJournal of immunology (Baltimore, Md. : 1950)
Volume198
Issue number2
Pages (from-to)729-740
Number of pages12
ISSN0022-1767
DOIs
Publication statusPublished - 15 Jan 2017

ID: 49819702